Lynn Paseltiner

Lynn Paseltiner is an accomplished inventor based in Monroe, NY (US). She has made significant contributions to the field of hematology through her innovative inventions. With a total of 3 patents, her work focuses on improving the accuracy and efficiency of blood analysis.

Latest Patents

One of her latest patents is a fully automated method and reagent composition for rapid determination of reticulocyte and erythrocyte counts, as well as platelet counts in whole blood samples. This invention utilizes a zwitterionic surfactant as a sphering agent and an organic cationic dye, such as Oxazine 750, to stain reticulocytes. The method allows for blood sample analyses to be completed in less than 30 seconds, significantly enhancing the speed of laboratory processes.

Another notable patent is a highly sensitive and accurate method for the discrimination and quantification of platelets in whole blood samples. This invention provides precise measurements of platelet dry mass and component concentration, which can be crucial for assessing the activation state of platelets. The method is applicable to both normal and abnormal blood samples, offering valuable insights for clinicians.

Career Highlights

Lynn Paseltiner is currently employed at Bayer Corporation, where she continues to develop innovative solutions in the field of hematology. Her work has been instrumental in advancing automated blood analysis technologies.

Collaborations

She has collaborated with notable colleagues, including David Zelmanovic and Gregory M Colella, to further enhance her research and development efforts.

Conclusion

Lynn Paseltiner's contributions to hematology through her patents demonstrate her commitment to innovation and improving medical diagnostics. Her work continues to impact the field positively, making blood analysis faster and more accurate.